Krystal Biotech is a fully integrated, commercial-stage biotechnology company focused on discovery, development, manufacturing, and commercialization of genetic medicines using a patented HSV-1-based gene therapy platform. Its first commercial product, VYJUVEK (beremagene geperpavec-svdt), is approved in the US, EU, and Japan for dystrophic epidermolysis bullosa (DEB). The company operates two in-house CGMP manufacturing facilities and has a pipeline of clinical-stage candidates for rare and serious diseases, including NSCLC and aesthetic conditions.
Q2 FY2026 — expected 2026-08-15
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-17 | 2025-12-31 | 0001711279-26-000016 | EDGAR | 86K words |
| 2025-02-19 | 2024-12-31 | 0001711279-25-000008 | EDGAR | 87K words |
| 2024-02-26 | 2023-12-31 | 0001711279-24-000005 | EDGAR | 82K words |
| 2023-02-27 | 2022-12-31 | 0001711279-23-000008 | EDGAR | 66K words |
| 2022-02-28 | 2021-12-31 | 0001711279-22-000004 | EDGAR | — |
| 2021-03-01 | 2020-12-31 | 0001711279-21-000006 | EDGAR | — |
| 2020-03-10 | 2019-12-31 | 0001564590-20-009550 | EDGAR | — |
| 2019-03-12 | 2018-12-31 | 0001564590-19-007267 | EDGAR | — |
| 2018-03-12 | 2017-12-31 | 0001564590-18-005252 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-03 | 2026-06-30 | 0001711279-26-000057 | EDGAR | 17K words |
| 2025-11-03 | 2025-09-30 | 0001711279-25-000087 | EDGAR | 19K words |
| 2025-08-04 | 2025-06-30 | 0001711279-25-000077 | EDGAR | 27K words |
| 2025-05-06 | 2025-03-31 | 0001711279-25-000044 | EDGAR | 50K words |
| 2024-11-04 | 2024-09-30 | 0001711279-24-000056 | EDGAR | 50K words |
| 2024-08-05 | 2024-06-30 | 0001711279-24-000040 | EDGAR | 50K words |
| 2024-05-06 | 2024-03-31 | 0001711279-24-000020 | EDGAR | 47K words |
| 2023-11-06 | 2023-09-30 | 0001711279-23-000073 | EDGAR | 36K words |
| 2023-08-07 | 2023-06-30 | 0001711279-23-000064 | EDGAR | 33K words |
| 2023-05-08 | 2023-03-31 | 0001711279-23-000029 | EDGAR | 19K words |
| 2022-11-07 | 2022-09-30 | 0001711279-22-000058 | EDGAR | — |
| 2022-08-08 | 2022-06-30 | 0001711279-22-000047 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-03 | 0001711279-26-000058 | EDGAR | 4K words |
| 2026-07-21 | 0001711279-26-000050 | EDGAR | 1K words |
| 2026-02-17 | 0001711279-26-000018 | EDGAR | 4K words |
| 2026-01-12 | 0001711279-26-000008 | EDGAR | 1K words |
| 2026-01-08 | 0001711279-26-000005 | EDGAR | 2K words |
| 2025-12-23 | 0001711279-25-000092 | EDGAR | 1K words |
| 2025-11-03 | 0001711279-25-000088 | EDGAR | 4K words |
| 2025-10-22 | 0001711279-25-000082 | EDGAR | 1K words |
| 2025-08-04 | 0001711279-25-000078 | EDGAR | 4K words |
| 2025-07-25 | 0001711279-25-000071 | EDGAR | 1K words |
167 total filings indexed. 136 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001711279 |
| Ticker | KRYS |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Website | https://www.krystalbio.com |
| Listed | 2017-09-20 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/KRYS (~200 tokens, structured JSON with cryptographic provenance)